Hims & Hers Health (HIMS) Cash from Investing Activities (2019 - 2026)

Hims & Hers Health's (HIMS) quarterly Cash from Investing Activities came in at -$15.4 million in Q1 2026, up 52.9% year-on-year from -$10.1 million in Q1 2025, and up 81.54% quarter-over-quarter from -$83.7 million in Q4 2025.

Hims & Hers Health (HIMS) Cash from Investing Activities (2019 - 2026) Analysis & Trends

Hims & Hers Health has disclosed Cash from Investing Activities across 8 years of filings, most recently posting -$15.4 million for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$15.4 million, up 52.9% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.0 billion (down 1452.89% YoY), and the FY2025 annual result was -$1.0 billion, down 5280.92% from the prior year.
  • Cash from Investing Activities came in at -$15.4 million for Q1 2026 at Hims & Hers Health, up from -$83.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $20.7 million in Q4 2023 to a low of -$887.4 million in Q3 2025.
  • The 5-year median for Cash from Investing Activities is -$4.5 million (2024), against an average of -$61.0 million.
  • Across the five-year window, Cash from Investing Activities jumped 417.09% in 2024 and slumped 8421.2% in 2025, its largest moves.
  • Hims & Hers Health's Cash from Investing Activities stood at $6.0 million in 2022, then soared by 244.74% to $20.7 million in 2023, then tumbled by 183.14% to -$17.2 million in 2024, then plunged by 386.32% to -$83.7 million in 2025, then surged by 81.54% to -$15.4 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$15.4 million (Q1 2026), -$83.7 million (Q4 2025), and -$887.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn -2.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -15.45 Mn
Mar 31, 2026 -15.45 Mn
Dec 31, 2025 -83.68 Mn
Dec 31, 2025 -83.68 Mn
Sep 30, 2025 -887.40 Mn
Sep 30, 2025 -887.40 Mn
Jun 30, 2025 -21.09 Mn
Jun 30, 2025 -21.09 Mn
Mar 31, 2025 -32.80 Mn
Mar 31, 2025 -32.80 Mn
Dec 31, 2024 -17.21 Mn
Dec 31, 2024 -17.21 Mn
Sep 30, 2024 -10.41 Mn
Sep 30, 2024 -10.41 Mn
Jun 30, 2024 -4.47 Mn
Jun 30, 2024 -4.47 Mn
Mar 31, 2024 13.04 Mn
Mar 31, 2024 13.04 Mn
Dec 31, 2023 20.70 Mn
Dec 31, 2023 20.70 Mn